This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Da Silva EN, et al. Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome. Journal of Allergy and Clinical Immunology: In Practice 1: 687-688, No. 6, Nov 2013. Available from: URL: http://dx.doi.org/10.1016/j.jaip.2013.07.004 - Australia
About this article
Cite this article
Bee venom allergy immunotherapy. Reactions Weekly 1483, 21 (2014). https://doi.org/10.1007/s40278-014-7902-8